Alkemy Capital Investments has been readmitted to the standard list after it set up a new subsidiary to potentially supply lithium hydroxide monohydrate to battery manufacturers. The new plant could be set up at Teesside in the freeport. The board is assessing the prospects for the project and a feasibility study should be delivered at the end of March.
There is an exclusivity agreement, so the board has time to decide whether the project is going to be commercial. If Alkemy Capital does decide to go ahead it will need to recruit a chief executive and raise more funding.
The shares were...
